Colucid Pharma Cmn (CLCD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2014 | 12-2013 | |
| Assets | ||
| Current Assets | ||
| Cash & Cash Equivalents | N/A | 330 |
| TOTAL | $N/A | $330 |
| Non-Current Assets | ||
| Other Non-Current Assets | 0 | 2 |
| TOTAL | $N/A | $2 |
| Total Assets | $N/A | $330 |
| Liabilities | ||
| Current Liabilities | ||
| Accounts payable and accrued liabilities | 0 | 50 |
| Accrued Expenses | N/A | 1,560 |
| TOTAL | $N/A | $10,240 |
| Non-Current Liabilities | ||
| TOTAL | $N/A | $0 |
| Total Liabilities | $N/A | $10,240 |
| Shareholders' Equity | ||
| Retained earnings | N/A | -51,520 |
| Other shareholders' equity | 0 | 40,280 |
| TOTAL | $N/A | $-9,900 |
| Total Liabilities And Equity | $0 | $340 |